Home
/
Conditions
/ Hormone Imbalance
Hormonal Health
Schedule a Consultation
Hormone Imbalance
Hormone imbalance is rarely a problem with a single hormone in isolation. The endocrine system is a network of interconnected signals where cortisol affects thyroid conversion, insulin affects sex hormone binding, estrogen affects thyroid receptor sensitivity, and testosterone affects metabolic function. Restoring hormonal balance requires understanding the entire network, not just the one number that falls outside the reference range.
Hormonal HealthSystems-BasedOptimizable
Interconnectedevery hormonal axis affects every other; imbalance in one cascades through the system
Root Causesstress, metabolic dysfunction, gut health, and nutrition all drive hormonal dysregulation
Optimizablewhen the full hormonal network is evaluated and the upstream drivers are corrected
← Back to Conditions
Category: Hormonal Health | Also addressed: Hormonal Dysfunction, Multi-Axis Hormonal Imbalance, Endocrine Disruption
What Is Hormone Imbalance?
Hormone imbalance in functional medicine does not refer to a single hormone in isolation. It refers to the disruption of the hormonal communication network in which the sex hormones, thyroid hormones, adrenal hormones, and metabolic hormones including insulin and leptin all interact through shared feedback loops, shared precursor pools, and shared receptor systems. A change in any one axis reliably affects the others. What presents as low testosterone is often downstream of insulin resistance and cortisol excess. What presents as estrogen dominance is often downstream of progesterone deficiency from anovulatory cycles and impaired hepatic estrogen metabolism. Treating any single hormone in isolation without evaluating the full axis consistently produces incomplete and temporary results.
Key principle: Hormones do not operate in silos. Cortisol excess suppresses thyroid T4-to-T3 conversion and reduces sex hormone production by diverting the shared pregnenolone precursor pool toward cortisol synthesis. Insulin resistance drives testosterone reduction in men and estrogen excess in women through aromatase upregulation. The DUTCH complete test, evaluating sex hormones, cortisol patterns, and their metabolites in a single urine collection, is the only assessment that captures the full hormonal picture simultaneously.
Why It Matters
Hormonal imbalance drives symptoms across every system including energy, body composition, mood, cognitive function, libido, sleep architecture, immune regulation, and cardiovascular risk. Imbalance in any direction produces consequences across all of these domains simultaneously, which is why hormonal patients so often present with multi-system symptom clusters that do not fit any single conventional diagnosis.
Why Comprehensive Evaluation Matters
- Standard panels capture only a fraction of the picture: total testosterone without free testosterone misses bioavailability; FSH and estradiol without progesterone misses the ratio critical for perimenopausal women; TSH alone misses conversion, autoimmune status, and available active hormone
- Hormonal imbalance drives the chronic disease epidemic: insulin resistance and cortisol dysregulation are among the most prevalent hormonal imbalances and are primary drivers of metabolic syndrome, cardiovascular disease, and neurodegenerative conditions
- Multi-axis imbalances from a single upstream cause: the patient with low testosterone, subclinical hypothyroidism, and estrogen dominance simultaneously may have one upstream driver in HPA axis hyperactivation from sleep apnea or insulin resistance
- Hormonal optimization is one of the highest-impact clinical interventions available: addressing the full axis produces improvements in body composition, energy, cognitive function, and disease risk that pharmacological treatment of individual downstream conditions cannot match
Systems Regulated by Hormonal Balance
- Energy and metabolism: thyroid hormone, cortisol, and insulin collectively regulate cellular energy production, glucose availability, and metabolic rate at every level
- Body composition: testosterone, estrogen, cortisol, and insulin determine the balance between muscle synthesis, fat storage, and fat distribution across all tissue compartments
- Neurological function: sex hormones, thyroid hormone, and cortisol all directly regulate hippocampal function, neurotransmitter synthesis, and the cognitive clarity and emotional stability that patients describe as mental sharpness
- Sleep architecture: progesterone supports GABA-mediated sleep onset; cortisol must fall to near zero for sleep initiation; growth hormone is released primarily during slow-wave sleep; hormonal balance at night determines sleep quality
Common Symptoms
The symptom profile of hormonal imbalance is broad and nonspecific, which is why it is so frequently attributed to aging, stress, or overwork rather than investigated as a hormonal network problem. When multiple symptoms from the clusters below are present simultaneously, a comprehensive hormonal evaluation is warranted.
Energy and Mood
- Persistent fatigue not explained by sleep quantity or quality
- Mood instability, anxiety, or depression without clear psychological cause
- Reduced motivation and emotional flatness
- Afternoon energy crashes not present in earlier years
- Poor stress tolerance and disproportionate reactivity to minor demands
Body Composition and Physical
- Weight gain, particularly abdominal, resistant to diet and exercise changes
- Loss of muscle mass despite consistent resistance training
- Hair loss, dry skin, or changes in skin, hair, and nail quality
- Reduced libido in both men and women
- Irregular or heavy menstrual cycles and worsening PMS in women
Neurological and Sleep
- Brain fog, memory difficulties, and reduced cognitive sharpness
- Sleep disruption, difficulty falling or staying asleep
- Hot flashes or night sweats from estrogen fluctuations
- Cold intolerance, slow metabolism, or constipation from thyroid insufficiency
- Erectile dysfunction or reduced sexual function in men
Root Causes: A Functional Medicine Perspective
Before initiating hormonal replacement of any kind, identifying the mechanism driving the imbalance guides both the treatment decision and the approach. Upstream drivers determine both which hormones are affected and which interventions have the most durable impact.
The HPA-HPG-Thyroid Axis Interaction
Cortisol from chronic stress or HPA axis dysregulation suppresses gonadotropin-releasing hormone pulsatility, reducing LH, FSH, testosterone, and estradiol. It competes with progesterone for shared glucocorticoid receptors and suppresses the deiodinase enzymes converting T4 to active T3. DHEA production falls as the shared pregnenolone precursor is diverted toward cortisol synthesis. The patient presenting with low testosterone, subclinical hypothyroidism, and progesterone deficiency simultaneously may have a single upstream cause in HPA axis hyperactivation from sleep apnea, gut dysbiosis, or reactive hypoglycemia.
Insulin Resistance as a Hormonal Driver
Insulin resistance elevates insulin levels, which increases aromatase activity converting testosterone to estrogen in adipose tissue, reduces sex hormone-binding globulin, and drives luteinizing hormone pulsatility disruption. In women, this produces the androgen excess and anovulation of PCOS. In men, it produces the visceral fat-driven testosterone-to-estrogen conversion that compounds hypogonadism. Metabolic hormonal evaluation including fasting insulin and HOMA-IR is mandatory in any patient with sex hormone imbalance.
Gut Dysbiosis and the Estrobolome
The estrobolome is the collection of gut bacteria that metabolize estrogen through the enterohepatic circulation. Beta-glucuronidase-producing gut bacteria deconjugate hepatically-processed estrogen in the gut lumen, allowing reabsorption and recirculation rather than excretion. Elevated fecal beta-glucuronidase from gut dysbiosis produces estrogen excess independent of ovarian estrogen production. GI-MAP stool analysis includes fecal beta-glucuronidase, making it a direct window into the gut-estrogen connection that serum estradiol alone cannot reveal.
Nutritional Deficiencies Impairing Hormone Synthesis
Zinc is required for testosterone synthesis and 5-alpha-reductase regulation. Magnesium is required at multiple points in steroidogenesis and is rapidly depleted by chronic stress. Vitamin D is a steroid hormone precursor that directly supports testosterone synthesis in Leydig cells; deficiency reduces testosterone in men through a documented and reversible mechanism. Iodine and selenium are required for thyroid hormone synthesis and T4-to-T3 conversion respectively. Correcting these nutritional deficiencies is a prerequisite for hormonal optimization, not an adjunct to it.
Conventional vs Functional Medicine Approach
Conventional medicine approaches hormone imbalance through single-hormone replacement: testosterone for low testosterone, levothyroxine for low thyroid, exogenous estrogen for menopause. These are often appropriate and necessary interventions. What they frequently miss is the upstream hormonal axis disruption driving the deficiency and the downstream consequences of replacing one hormone without evaluating what it is doing to the entire network. Functional medicine evaluates the complete hormonal network simultaneously and targets upstream drivers before or alongside replacement when indicated.
| Domain | Conventional Medicine | Functional Medicine |
|---|---|---|
| Evaluation | Single hormone at a time; total testosterone, TSH, FSH/LH; often not free fractions or metabolites | DUTCH complete urine hormones, four-point salivary cortisol, free testosterone, fasting insulin, full thyroid axis including Free T3 and antibodies |
| Threshold | Laboratory lower reference limit; treat when below range | Optimal function range based on symptom burden and clinical pattern, not population average lower limit |
| Root cause | Rarely investigated; replacement initiated regardless of upstream mechanism | Insulin resistance, HPA axis dysfunction, gut estrobolome, and nutritional deficiencies identified and addressed before or alongside replacement |
| Metabolite evaluation | Not assessed; serum levels only | DUTCH metabolite patterns identify estrogen detoxification pathways, cortisol production versus clearance, and androgen conversion efficiency |
| Monitoring | Serum hormone levels and organ-specific safety markers | Serum plus urinary metabolites, symptom assessment, metabolic markers, and repeat DUTCH at 3 months after any replacement change |
Key Labs to Evaluate
A complete evaluation requires markers that characterize both the condition and the upstream drivers producing it.
Sex Hormones and Metabolites
DUTCH Complete TestThe most comprehensive single hormonal assessment: sex hormone metabolites, cortisol pattern, melatonin, and DHEA in one collection.
→Free TestosteroneBioavailable testosterone; more clinically relevant than total testosterone when SHBG is elevated.
→EstradiolPrimary estrogen; evaluate in context of progesterone, SHBG, and urinary metabolite patterns, not as a standalone.
→Adrenal, Thyroid, and Metabolic Context
Cortisol (4-Point Salivary)Diurnal cortisol pattern and cortisol awakening response; the most impactful upstream hormonal driver.
→Free T3The active thyroid hormone available to cells; impaired by cortisol excess even when TSH is normal.
→Fasting InsulinThe metabolic driver of sex hormone imbalance through aromatase and SHBG effects; mandatory in all hormonal evaluations.
→How to Interpret These Labs Together
DUTCH metabolite patterns provide clinical information that serum levels cannot. Elevated 4-OHE1 relative to 2-OHE1 estrogen metabolites identifies a detoxification pathway associated with increased cancer risk. Low 5-alpha-reductase metabolites despite adequate testosterone suggest conversion impairment. High cortisol metabolites with low free cortisol indicates high production with high clearance, a pattern requiring different management than low production with low clearance.
Free testosterone and SHBG together tell the story that total testosterone obscures. High SHBG from subclinical hypothyroidism or liver dysfunction produces low free testosterone with normal total testosterone. Low SHBG from insulin resistance produces elevated free testosterone in women and can mask deficiency in men. Never interpret total testosterone without SHBG.
| Pattern | Clinical Implication |
|---|---|
| Low free testosterone with normal total testosterone and elevated SHBG | SHBG-driven bioavailability problem. Investigate thyroid function, liver, and insulin resistance as SHBG drivers. Treating the root cause often restores free testosterone without replacement. |
| Estrogen dominance symptoms with normal serum estradiol | Either progesterone deficiency from anovulatory cycles creating relative excess, or elevated gut beta-glucuronidase increasing estrogen recirculation. DUTCH metabolites and GI-MAP stool analysis clarify the mechanism. |
| Low testosterone, subclinical hypothyroidism, and adrenal dysregulation together | Multi-axis imbalance from a single upstream cause. Four-point cortisol and sleep apnea screening before prescribing multiple hormones may resolve all three axes by treating one upstream driver. |
| Hormone replacement not producing expected clinical results | Upstream drivers are not addressed. Insulin resistance preventing testosterone from reaching target tissues, or cortisol competing at GABA receptors blocking progesterone sleep benefits. Replacement dose cannot overcome an untreated upstream driver. |
| Elevated cortisol metabolites with low DHEA-S | Pregnenolone steal pattern. Chronic HPA activation is diverting the steroidogenic precursor pool away from sex hormones toward cortisol. HPA normalization is the primary intervention before sex hormone replacement. |
Common Patterns Seen in Patients
- Low free testosterone with normal total testosterone: the most common missed androgen deficiency presentation; SHBG elevated from subclinical hypothyroidism, liver dysfunction, or insulin resistance reduces bioavailable testosterone while total testosterone remains within range; this pattern is missed by total testosterone testing alone and requires free testosterone and SHBG to identify
- Estrogen dominance symptoms with normal serum estradiol: progesterone deficiency from anovulatory cycles creates relative estrogen excess; elevated fecal beta-glucuronidase from gut dysbiosis increases estrogen recirculation; both produce classic estrogen dominance symptoms including heavy periods, PMS, fibrocystic breasts, and mood instability without elevated serum estradiol
- Multi-axis hormonal imbalance resolving from one upstream intervention: the patient with low testosterone, subclinical hypothyroidism, and adrenal dysregulation simultaneously who has undiagnosed sleep apnea driving all three; treating sleep apnea produces simultaneous improvement across all three hormonal axes without individual hormone replacement
- Hormone replacement not producing expected results: testosterone replacement not improving energy because insulin resistance prevents testosterone from reaching target tissues; progesterone not improving sleep because cortisol elevation is competing at the GABA receptor; replacement dose cannot overcome an untreated upstream driver
Treatment and Optimization Strategy
Addressing Metabolic and HPA Root Causes First
The highest-leverage hormonal intervention is identifying and treating the upstream driver producing the imbalance before or alongside any hormone replacement. Insulin resistance treatment through low glycemic load nutrition, resistance training, and berberine or metformin when appropriate reduces aromatase activity, increases SHBG toward normal, and improves testosterone bioavailability in men. HPA axis normalization through four-point cortisol assessment and pattern-specific intervention removes the cortisol-mediated suppression of sex hormone and thyroid function that no amount of replacement can overcome while the upstream driver remains active.
Foundational Metabolic and Nutritional Support
- Insulin resistance treatment: low glycemic load nutrition, resistance training, berberine (500mg three times daily with meals) or metformin when appropriate; reduces aromatase activity and SHBG reduction producing sex hormone imbalance; addresses the most common upstream driver in both men and women
- HPA axis normalization: four-point salivary cortisol plus DUTCH identifies the pattern; ashwagandha KSM-66 (600mg daily) for hyperactivation; rhodiola rosea (400mg morning) for depletion; morning bright light and consistent sleep timing as circadian anchors; eliminates cortisol-mediated suppression of thyroid conversion and sex hormone production
- Nutritional deficiency correction: zinc (15 to 30mg daily) for testosterone synthesis and 5-alpha-reductase regulation; vitamin D3 to 60 to 80 ng/mL for sex hormone and thyroid support; selenium (200mcg daily) for T4-to-T3 conversion; magnesium glycinate (400 to 600mg daily) for steroidogenesis and cortisol regulation
- Gut estrobolome optimization: GI-MAP identification of beta-glucuronidase-producing species; targeted dysbiosis treatment reducing estrogen recirculation; DIM (200mg daily) supporting 2-OH estrogen metabolism toward the favorable pathway
Bioidentical Hormone Replacement When Indicated
- Bioidentical testosterone: injectable testosterone cypionate or enanthate, topical gels or creams, or subcutaneous pellets; delivery method individualized by patient preference, lifestyle, fertility goals, and conversion patterns; monitoring includes free testosterone, estradiol, hematocrit, and PSA at 6 to 8 weeks after initiation or dose change
- Bioidentical progesterone: oral micronized progesterone (Prometrium or compounded) 100 to 200mg nightly for luteal phase support or continuously when cycles are very irregular; improves sleep through GABA-A allopregnanolone modulation; reduces PMS and cycle-phase mood symptoms; provides endometrial protection with a more favorable profile than synthetic progestins
- Thyroid optimization beyond TSH: Free T3 in the upper half of the reference range as the target for symptomatic patients; T4-to-T3 conversion addressed with selenium and cortisol reduction before adding T3 supplementation; compounded T4/T3 combination or desiccated thyroid for patients whose conversion impairment is persistent despite upstream treatment
- DUTCH-guided monitoring: repeat DUTCH at 3 months after any replacement change; evaluates metabolite patterns, not just serum levels; ensures estrogen detoxification is proceeding through favorable pathways; adjusts replacement based on the full hormonal picture rather than a single serum value
What Most Doctors Miss
- Free testosterone is not measured: total testosterone without SHBG and free testosterone provides an incomplete and frequently misleading picture of androgen status; the number that matters clinically is the free fraction, and it is the number most commonly not ordered in conventional hormonal evaluation
- The metabolic hormonal connection is not evaluated: fasting insulin and HOMA-IR are not included in standard hormonal workups despite insulin resistance being one of the most impactful and most reversible drivers of sex hormone imbalance in both men and women
- Cortisol is not assessed: HPA axis dysregulation is the most common single upstream cause of multi-axis hormonal imbalance and is not included in standard hormonal evaluation despite the fact that cortisol directly suppresses every other hormonal axis simultaneously
- Hormone metabolites are not evaluated: serum estradiol tells you how much estrogen is in circulation; DUTCH testing tells you which detoxification pathways it is going through and whether the pattern is clinically favorable; replacing estrogen without knowing the metabolite pattern is clinically incomplete
- Upstream causes are not addressed before replacement: prescribing testosterone replacement without identifying the insulin resistance or sleep apnea driving the deficiency produces dependency on replacement rather than restoration of endogenous function; the root cause continues operating while the deficiency is masked
When to Seek Medical Care
Seek prompt evaluation for: rapidly progressive symptoms of hormone deficiency that are impairing daily function, suspected pituitary or hypothalamic pathology including severe headaches with hormonal changes or visual field changes, symptoms of hormone excess from replacement including polycythemia from testosterone or significant mood changes, or any newly diagnosed adrenal insufficiency requiring medical management. For the broad spectrum of functional hormonal imbalance producing fatigue, weight changes, mood symptoms, and cognitive complaints without acute organ threat, comprehensive functional evaluation and root-cause treatment is the appropriate and effective first-line approach.
Recommended Testing
Identifying the root cause of this condition requires going beyond standard labs. The following markers provide the most clinically useful insights.
Foundational Labs
- DUTCH Complete Test
- Free Testosterone
- Estradiol
Advanced Assessment
- TSH
- Free T3
- Cortisol (4-Point)
- Fasting Insulin
- SHBG
Not sure which testing applies to you?
Explore All Testing Options →Frequently Asked Questions
Is DUTCH testing better than blood testing for hormones?
DUTCH and serum testing measure different things and provide complementary information. Serum testing captures the circulating hormone level at a single point in time. DUTCH captures hormone metabolites in urine over a collection period, providing information about how the body is processing and detoxifying hormones, which pathways they are going through, how much total hormone is being produced versus cleared, and what the diurnal cortisol pattern looks like. For sex hormones specifically, DUTCH metabolite patterns provide the estrogen detoxification pathway information and cortisol pattern data that serum testing fundamentally cannot capture. The most comprehensive evaluation uses both.
Can hormonal imbalance cause depression?
Yes, through multiple direct mechanisms. Testosterone deficiency reduces dopamine and serotonin synthesis and receptor sensitivity in men and women. Progesterone deficiency removes the allopregnanolone metabolite that provides GABA-A positive modulation, the same anxiolytic mechanism that benzodiazepines target. Thyroid hormone deficiency reduces serotonin synthesis and receptor density. Cortisol dysregulation directly impairs hippocampal function and the prefrontal cortical regulation of mood and emotional reactivity. Many patients diagnosed with depression or anxiety have an underlying hormonal driver that antidepressants cannot address but hormonal optimization can.
At what age does hormonal decline begin?
Testosterone in men begins declining at approximately 1 to 2% per year from age 30, with a clinically noticeable decline typically appearing in the mid-40s. Progesterone in women begins declining earlier, as anovulatory cycles with reduced progesterone start appearing in the late 30s. DHEA peaks in the mid-20s and declines throughout adulthood. Thyroid conversion efficiency decreases with age. These are averages; significant individual variation exists, and lifestyle factors including sleep quality, stress burden, body composition, and metabolic health dramatically accelerate or slow age-related hormonal decline.
Does hormone replacement increase cancer risk?
Risk depends on which hormones, which forms, which routes of delivery, and the individual patient's specific risk profile. Bioidentical micronized progesterone does not carry the breast cancer risk associated with synthetic progestins used in the WHI study. Transdermal estradiol does not increase venous thromboembolism risk as oral estrogen does. Testosterone replacement at physiological levels in men does not increase prostate cancer risk in current evidence. The risk profile of bioidentical hormones at physiological doses is substantially different from the synthetic hormones studied in the WHI, and this distinction is critical and frequently absent from patient counseling.
How The Lamkin Clinic Approaches Hormone Imbalance
Clinical Perspective
We treat the hormonal network, not individual hormones. A patient who comes in with low testosterone, brain fog, and weight gain around the middle has three visible problems and probably one root cause. We run the DUTCH, we run the four-point cortisol, we check fasting insulin and HOMA-IR, and very often we find that the testosterone is low because the insulin resistance is driving aromatase and the cortisol excess is suppressing LH. Treating the insulin resistance and normalizing the cortisol pattern frequently brings the testosterone up without any replacement at all. When we do need to replace, we do it comprehensively: monitoring the metabolite patterns, managing the downstream conversion, and checking the full hormonal axis at every interval rather than a single number that tells us almost nothing about what is actually happening biochemically.
Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma
Related Conditions
Adrenal DysfunctionHPA axis dysregulation is the most common upstream driver of multi-axis hormonal imbalance
→Thyroid DysfunctionThyroid hormone affects sex hormone metabolism, SHBG production, and the entire hormonal axis
→Insulin ResistanceMetabolic insulin resistance drives aromatase excess, SHBG reduction, and sex hormone imbalance
→Estrogen DominanceRelative estrogen excess from progesterone deficiency or gut dysbiosis; the most common sex hormone imbalance in women
→Low TestosteroneTestosterone deficiency in men; frequently downstream of metabolic and HPA axis dysfunction
→Related Symptoms
FatigueEvery hormonal axis contributes to energy production; imbalance in any produces persistent fatigue
→Brain FogSex hormones, thyroid, and cortisol all directly regulate cognitive function and mental clarity
→Weight GainInsulin, cortisol, testosterone, and thyroid collectively regulate body composition and fat distribution
→Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.
Hormonal imbalance requires evaluation of the full network, not a single marker.
The Lamkin Clinic provides comprehensive multi-axis hormonal evaluation including DUTCH complete testing, adrenal axis assessment, thyroid conversion evaluation, and metabolic hormonal drivers. Schedule a consultation for a complete hormonal network assessment.
Schedule a ConsultationMedical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.